Autologous dendritic cell vaccine (UNC Lineberger Comprehensive Cancer Center)

N/A

Report date: 2022/11/27 23:59:50

Base Information

Drug NameAutologous dendritic cell vaccine (UNC Lineberger Comprehensive Cancer Center)

Drug Alias Name自体树突状细胞疫苗-UNC Lineberger Comprehensive Cancer Center

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUnc Lineberger Comprehensive Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesUnc Lineberger Comprehensive Cancer Center

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A